{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:57:21Z","timestamp":1791212241136,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jbspin.2015.06.002","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T22:24:10Z","timestamp":1436826250000},"page":"308-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Uveitis in adults: What do rheumatologists need to know?"],"prefix":"10.1016","volume":"82","author":[{"given":"Pascal","family":"S\u00e8ve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Kodjikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9opold","family":"Ad\u00e9la\u00efde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Jamilloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2015.06.002_bib0305","series-title":"\u0152il et maladies syst\u00e9miques","first-page":"60","article-title":"Uv\u00e9ites","author":"Bentaleb-Machkour","year":"2014"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0310","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.revmed.2008.08.011","article-title":"[Guidelines for the management of uveitis in internal medicine]","volume":"30","author":"Abad","year":"2009","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0315","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrrheum.2013.185","article-title":"Ocular inflammatory diseases associated with rheumatoid arthritis","volume":"10","author":"Artifoni","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0320","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0325","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajo.2013.03.027","article-title":"Approach to the diagnosis of the uveitides","volume":"156","author":"Jabs","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0330","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.semarthrit.2011.10.006","article-title":"Patients with retinal vasculitis rarely suffer from systemic vasculitis","volume":"41","author":"Rosenbaum","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0335","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.ophtha.2014.07.007","article-title":"Long-term clinical outcome and causes of vision loss in patients with uveitis","volume":"121","author":"Tomkins-Netzer","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0340","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.revmed.2006.05.014","article-title":"[Interest of an internist's consultation in uveitis. Comparative study in 66 cases]","volume":"27","author":"Le Scanff","year":"2006","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0345","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3899\/jrheum.080102","article-title":"Uveitis subtypes in a German interdisciplinary uveitis center: analysis of 1916 patients","volume":"36","author":"Jakob","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0350","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ophtha.2011.07.013","article-title":"Clinical characteristics of a large cohort of patients with scleritis and episcleritis","volume":"119","author":"Sainz de la Maza","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0355","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/archophthalmol.2012.2006","article-title":"Bilateral simultaneous-onset nongranulomatous acute anterior uveitis: clinical presentation and etiology","volume":"130","author":"Birnbaum","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0360","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/09273948.2011.580071","article-title":"Characteristics of uveitis presenting for the first time in the elderly: analysis of 91 patients in a tertiary center","volume":"19","author":"Gregoire","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0365","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/art.503","article-title":"Management of uveitis: a rheumatologic perspective","volume":"46","author":"Rosenbaum","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0370","series-title":"Diagnosis and treatment of uveitis","first-page":"79","article-title":"Diagnosis of uveitis","author":"Harper","year":"2002"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0375","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.autrev.2014.04.001","article-title":"Sarcoidosis and uveitis","volume":"13","author":"Jamilloux","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0380","doi-asserted-by":"crossref","first-page":"863418","DOI":"10.1155\/2012\/863418","article-title":"Vitreous analysis in the management of uveitis","volume":"2012","author":"Damato","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0385","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MD.0b013e31817b0747","article-title":"High prevalence of fastidious bacteria in 1520 cases of uveitis of unknown etiology","volume":"87","author":"Drancourt","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0390","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0395","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ajo.2009.11.019","article-title":"The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics","volume":"149","author":"Kempen","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0400","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0405","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.semarthrit.2010.05.008","article-title":"Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis","volume":"40","author":"Pato","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0410","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.ophtha.2014.04.023","article-title":"A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis","volume":"121","author":"Rathinam","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0415","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2013.02.002","article-title":"Biotherapies in inflammatory ocular disorders: interferons, immunoglobulins, monoclonal antibodies","volume":"12","author":"Saadoun","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0420","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.revmed.2014.07.008","article-title":"Biologics in uveitis","volume":"36","author":"Feurer","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0425","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","article-title":"Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders","volume":"121","author":"Levy-Clarke","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0430","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.semarthrit.2006.08.004","article-title":"Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis","volume":"36","author":"Lassoued","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0435","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ophtha.2012.10.028","article-title":"The incidence of acute anterior uveitis after intravenous zoledronate","volume":"120","author":"Patel","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0440","doi-asserted-by":"crossref","first-page":"E431","DOI":"10.1503\/cmaj.111752","article-title":"Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study","volume":"184","author":"Etminan","year":"2012","journal-title":"CMAJ"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0445","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1750-1172-7-57","article-title":"Uveitis: a rare disease often associated with systemic diseases and infections: a systematic review of 2619 patients","volume":"7","author":"Barisani-Asenbauer","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0450","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","article-title":"Statement on sarcoidosis","volume":"160","author":"Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0455","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semarthrit.2011.12.006","article-title":"Efficacy and safety of TNF antagonists in sarcoidosis: data from the Spanish registry of biologics BIOBADASER and a systematic review","volume":"42","author":"Maneiro","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0460","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1172-7-20","article-title":"Beh\u00e7et's disease","volume":"7","author":"Saadoun","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0465","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00005792-200107000-00005","article-title":"Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center","volume":"80","author":"Bodaghi","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0470","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Beh\u00e7et disease: an analysis of 880 patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0475","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ajo.2011.05.032","article-title":"Beh\u00e7et disease: visual prognosis and factors influencing the development of visual loss","volume":"152","author":"Taylor","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0480","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3109\/09273948.2012.723112","article-title":"Epidemiology of Beh\u00e7et disease","volume":"20","author":"Khairallah","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0485","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease","volume":"335","author":"International Study Group for Beh\u00e7et's Disease","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0490","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/acr.20308","article-title":"Azathioprine in severe uveitis of Beh\u00e7et's disease","volume":"62","author":"Saadoun","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0495","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","article-title":"EULAR recommendations for the management of Beh\u00e7et disease","volume":"67","author":"Hatemi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0500","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/ard.2007.075754","article-title":"Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review","volume":"67","author":"Zeboulon","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0505","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ophtha.2003.07.011","article-title":"Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases","volume":"111","author":"Monnet","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0510","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.survophthal.2005.04.003","article-title":"Acute anterior uveitis and HLA-B27","volume":"50","author":"Chang","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0515","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/bjo.84.4.413","article-title":"HLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population","volume":"84","author":"Huhtinen","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0520","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ophtha.2006.01.004","article-title":"Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations","volume":"113","author":"El-Shabrawi","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0525","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1111\/aos.12104","article-title":"Role of IL-10 gene polymorphisms in intermediate and HLA-B27-associated uveitis","volume":"91","author":"Lindner","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0530","doi-asserted-by":"crossref","first-page":"e62244","DOI":"10.1371\/journal.pone.0062244","article-title":"Association between polymorphism of the vitamin D metabolism gene CYP27B1 and HLA-B27-associated uveitis. Is a state of relative immunodeficiency pathogenic in HLA B27-positive uveitis?","volume":"8","author":"Steinwender","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0535","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00417-014-2772-6","article-title":"Acute anterior uveitis and undiagnosed spondyloarthritis: usefulness of Berlin criteria","volume":"253","author":"Wach","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0540","article-title":"A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool)","author":"Haroon","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0545","series-title":"\u0152il et maladies syst\u00e9miques","first-page":"341","article-title":"Spondylarthropathies","author":"Monnet","year":"2014"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0555","first-page":"1277","article-title":"Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period","volume":"30","author":"Munoz-Fernandez","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0560","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/eye.2000.84","article-title":"Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis","volume":"14","author":"Benitez-Del-Castillo","year":"2000","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0565","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/art.21197","article-title":"Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept","volume":"52","author":"Braun","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0570","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/ard.2006.052092","article-title":"Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study","volume":"65","author":"Guignard","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0575","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.semarthrit.2011.05.005","article-title":"New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases","volume":"41","author":"Wendling","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0580","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3899\/jrheum.110865","article-title":"Scleritis: a paradoxical effect of etanercept? Etanercept-associated inflammatory eye disease","volume":"39","author":"Gaujoux-Viala","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0585","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","article-title":"Do tumor necrosis factor inhibitors cause uveitis? A registry-based study","volume":"56","author":"Lim","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0590","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/09273948.2011.623213","article-title":"Sarcoid-related uveitis occurring during adalimumab therapy","volume":"20","author":"Seve","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0595","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jbspin.2011.01.013","article-title":"The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients","volume":"78","author":"Dougados","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2015.06.002_bib0600","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/rheumatology\/kes026","article-title":"Update of the literature review on treatment with biologics as a basis for the first update of the ASAS\/EULAR management recommendations of ankylosing spondylitis","volume":"51","author":"Baraliakos","year":"2012","journal-title":"Rheumatology (Oxford)"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15001086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15001086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T01:48:55Z","timestamp":1566956935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X15001086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1297319X15001086"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.06.002","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uveitis in adults: What do rheumatologists need to know?","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}